RAD51D and ovarian cancer: An additional patient with an incidental finding of a unilateral, non-metastatic, secreting PCC tumor at age 31 years, carries a pathogenic variant in RAD51D gene that confers an autosomal dominant predisposition to breast and ovarian cancer (MedGen UID: 481975), but is not considered to be associated with a hereditary PGL/PCC syndrome (Table 2).